NCT04017026

Brief Summary

In this retrospective study, approximately 60 patients treated with 6mm short implants (Straumann, SLA (sandblasted, large-grit, acid-etched surface), SLActive (sandblasted, large-grit, acid-etched, hydrophilic surface), 4.1 or 4.8 mm in diameter) will be followed for 4.5-18.2 years. Clinical and radiographic parameters will be assessed in a follow-up examination.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 9, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2019

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 8, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 12, 2019

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

September 3, 2020

Status Verified

September 1, 2020

Enrollment Period

11 months

First QC Date

April 3, 2019

Last Update Submit

September 2, 2020

Conditions

Jaw, Edentulous, PartiallyDental Implant FailedImplant Complication

Keywords

Short dental implantPartially edentulous jaw

Outcome Measures

Primary Outcomes (1)

  • Implant survival rates

    Survival rates of short dental implants

    5-18 years

Secondary Outcomes (10)

  • Radiographic: Annual bone loss

    5-18 years

  • Clinically: modifying risk factors on implant survival and success

    5-18 years

  • Clinically: modifying risk factors on implant survival and success

    5-18 years

  • Clinically: modifying risk factors on implant survival and success

    5-18 years

  • Clinically: modifying risk factors on implant survival and success

    5-18 years

  • +5 more secondary outcomes

Study Arms (1)

6 mm implants

Patients were treated with 6mm short implants (Straumann, SLA, SLActive, 4.1 or 4.8 mm in diameter).

Device: Implantation

Interventions

ImplantationDEVICE

Implantation of 6 mm short implants

6 mm implants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients treated with a 6mm short implant at the University of Bern were recalled for a clinical and radiographic follow-up examination.

You may qualify if:

  • Partially or fully edentulous jaw
  • Written informed consent

You may not qualify if:

  • Pregnant women/lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department for oral surgery of the zmk Bern, University of Bern

Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

Jaw, Edentulous, Partially

Condition Hierarchy (Ancestors)

Jaw, EdentulousJaw DiseasesMusculoskeletal DiseasesStomatognathic DiseasesMouth, EdentulousMouth DiseasesTooth Diseases

Study Officials

  • Vivianne Chappuis, DMD

    University of Bern

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2019

First Posted

July 12, 2019

Study Start

May 9, 2018

Primary Completion

April 8, 2019

Study Completion

June 30, 2020

Last Updated

September 3, 2020

Record last verified: 2020-09

Locations

CH(1)